Latest Insider Transactions at Ventyx Biosciences, Inc. (VTYX)
This section provides a real-time view of insider transactions for Ventyx Biosciences, Inc. (VTYX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ventyx Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ventyx Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
William J. Sandborn Officer |
SELL
Open market or private sale
|
Direct |
21,760
-31.02%
|
$718,080
$33.87 P/Share
|
|
Dec 14
2022
|
William J. Sandborn Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,760
+9.61%
|
$21,760
$1.82 P/Share
|
|
Dec 13
2022
|
Somu Subramaniam |
SELL
Other acquisition or disposition
|
Indirect |
3,341,262
-20.11%
|
-
|
|
Dec 13
2022
|
John Nuss CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
35,000
-13.53%
|
$1,190,000
$34.32 P/Share
|
|
Dec 13
2022
|
Nsv Partners Iii LP |
SELL
Other acquisition or disposition
|
Indirect |
3,341,262
-20.11%
|
-
|
|
Dec 13
2022
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-9.91%
|
$1,020,000
$34.46 P/Share
|
|
Dec 05
2022
|
John Nuss CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-8.19%
|
$1,400,000
$28.65 P/Share
|
|
Dec 05
2022
|
Raju Mohan CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
23,003
-0.74%
|
$644,084
$28.74 P/Share
|
|
Dec 02
2022
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-14.18%
|
$1,450,000
$29.01 P/Share
|
|
Dec 02
2022
|
Martin Auster CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
97,647
-67.21%
|
$2,831,763
$29.01 P/Share
|
|
Dec 02
2022
|
Martin Auster CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+25.6%
|
$150,000
$3.45 P/Share
|
|
Dec 02
2022
|
Raju Mohan CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
276,997
-15.04%
|
$8,032,913
$29.01 P/Share
|
|
Dec 01
2022
|
Somu Subramaniam |
SELL
Open market or private sale
|
Indirect |
129,317
-0.77%
|
$3,750,193
$29.01 P/Share
|
|
Dec 01
2022
|
Nsv Partners Iii LP |
SELL
Open market or private sale
|
Indirect |
129,317
-0.77%
|
$3,750,193
$29.01 P/Share
|
|
Nov 30
2022
|
Somu Subramaniam |
SELL
Open market or private sale
|
Indirect |
143,228
-0.85%
|
$4,153,612
$29.01 P/Share
|
|
Nov 30
2022
|
Nsv Partners Iii LP |
SELL
Open market or private sale
|
Indirect |
143,228
-0.85%
|
$4,153,612
$29.01 P/Share
|
|
Nov 07
2022
|
Nsv Partners Iii LP |
SELL
Open market or private sale
|
Indirect |
3,935
-0.02%
|
$114,115
$29.08 P/Share
|
|
Nov 07
2022
|
Somu Subramaniam |
SELL
Open market or private sale
|
Indirect |
3,935
-0.02%
|
$114,115
$29.08 P/Share
|
|
Aug 23
2022
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
169,361
+21.37%
|
$0
$0.2 P/Share
|
|
Apr 03
2022
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-5.15%
|
$480,000
$32.88 P/Share
|
|
Apr 03
2022
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,447
+1.42%
|
$42,235
$5.79 P/Share
|
|
Oct 25
2021
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
625,000
+30.71%
|
$10,000,000
$16.0 P/Share
|
|
Oct 25
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
785,303
+50.0%
|
-
|
|
Oct 25
2021
|
Aaron Royston Director |
BUY
Open market or private purchase
|
Indirect |
312,500
+7.25%
|
$5,000,000
$16.0 P/Share
|
|
Oct 25
2021
|
Aaron Royston Director |
BUY
Conversion of derivative security
|
Indirect |
3,684,769
+50.0%
|
-
|
|
Oct 25
2021
|
Sheila Gujrathi |
BUY
Conversion of derivative security
|
Direct |
32,897
+50.0%
|
-
|
|
Oct 25
2021
|
Somu Subramaniam |
BUY
Conversion of derivative security
|
Indirect |
16,892,528
+50.0%
|
-
|
|
Oct 25
2021
|
Nsv Investments I, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
16,892,528
+50.0%
|
-
|
|
Oct 25
2021
|
Ven Bio Global Strategic Fund Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
312,500
+7.25%
|
$5,000,000
$16.0 P/Share
|
|
Oct 25
2021
|
Ven Bio Global Strategic Fund Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,684,769
+50.0%
|
-
|